Navigation Links
XTL to Present at the Arch Investment Conference
Date:9/5/2007

VALLEY COTTAGE, New York, September 5 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB; LSE: XTL; TASE: XTL), a biopharmaceutical company engaged in the acquisition, development and commercialization of therapeutics for the treatment of unmet medical needs, particularly neuropathic pain and hepatitis C, today announced today that Ron Bentsur, the Company's Chief Executive Officer, is scheduled to present at the Arch Investment Conference. Mr. Bentsur will present an overview of the Company including a discussion of Bicifadine, the Company's late-stage clinical compound for the treatment of neuropathic pain. Mr. Bentsur's presentation will take place, tomorrow, Thursday, September 6, 2007 at 11:30 pm Eastern Daylight Time, at the Warwick Hotel in New York City.

A live audio webcast of Mr. Bentsur's presentation will be available at: http://www.informedinvestors.com/VC/ClientPage.asp?ID=45356. An archived version of the webcast will be available following the conclusion of the live presentation.

ABOUT XTL BIOPHARMACEUTICALS LTD.

XTL Biopharmaceuticals Ltd. ("XTL") is engaged in the development of therapeutics for the treatment of neuropathic pain and hepatitis C. XTL is developing Bicifadine, a serotonin and norepinephrine reuptake inhibitor, for the treatment of diabetic neuropathic pain. XTL is also developing several novel pre-clinical hepatitis C small molecule inhibitors. XTL also has an active in-licensing and acquisition program designed to identify and acquire additional drug candidates. XTL is publicly traded on the NASDAQ, London, and Tel-Aviv Stock Exchanges (NASDAQ: XTLB; LSE: XTL; TASE: XTL).

Contact:

Ron Bentsur

Chief Executive Officer

Tel: +1-845-267-0707, ext. 225


'/>"/>
SOURCE XTL Biopharmaceuticals Ltd
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... Israel , May 31, 2016 ... the Rappaport Institute for Biomedical Research at the Technion - ... option and license agreement with Pfizer Inc. (NYSE: ... antibody into potential new treatment options for a number of ... a scientific breakthrough made by Prof. Nathan Karin ...
(Date:5/31/2016)... (PRWEB) , ... May 30, 2016 , ... Doctors in ... response may live longer than patients with lower levels. Surviving Mesothelioma has just posted ... , Researchers at cancer centers in Genoa and La Spezia, Italy tested the blood ...
(Date:5/31/2016)... Muncie, IN (PRWEB) , ... May 31, 2016 , ... ... National Model Aviation Museum that will be on display Memorial Day through Labor Day ... Earle-Chaffee, Henry Chaffee, and Clark Chaffee. , Bill Chaffee won first place for ...
(Date:5/27/2016)... Phoenix, AZ (PRWEB) , ... May 27, 2016 , ... ... 10 Morning News in Phoenix, Dr. Michael Fitzmaurice, hand surgeon and founder of the ... at the practice. The Wrist MRI machine is a state-of-the-art technology and only 1 ...
Breaking Biology Technology:
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
(Date:3/21/2016)... 2016 Unique technology combines ... superior security   Xura, Inc. ... secure digital communications services, today announced it is working ... enterprise customers, particularly those in the Financial Services Sector, ... authentication within a mobile app, alongside, and in combination ...
(Date:3/15/2016)... Yissum Research Development Company of the Hebrew University ... University, announced today the formation of Neteera Technologies ... biological indicators. Neteera Technologies has completed its first round ... Neteera,s ... from sweat ducts, enables reliable and speedy biometric identification, ...
Breaking Biology News(10 mins):